network,protocol,assay,isolate,pub_id,rx_code,rx_label,visitno,month,visit_label,celltype,tier,titer_txt,titer_num,response
HVTN,123,NAB,CH505.w4.3,123-43,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,295.23019,295.23019,1
HVTN,123,NAB,CH505.w4.3,123-43,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,108.560457,108.560457,1
HVTN,123,NAB,CH505TF,123-43,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-43,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-05,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-05,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,<10.0,5,0
HVTN,123,NAB,CH505TF,123-05,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-05,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-05,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-05,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,<10.0,5,0
HVTN,123,NAB,CH505TF,123-05,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-05,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-35,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,92.5644109,92.5644109,1
HVTN,123,NAB,CH505.w4.3,123-35,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,26.6785004,26.6785004,1
HVTN,123,NAB,CH505TF,123-35,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-35,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-35,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,1278.65264,1278.65264,1
HVTN,123,NAB,CH505.w4.3,123-35,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,314.326009,314.326009,1
HVTN,123,NAB,CH505TF,123-35,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-35,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-11,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,155.823157,155.823157,1
HVTN,123,NAB,CH505.w4.3,123-11,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,51.7792679,51.7792679,1
HVTN,123,NAB,CH505TF,123-11,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-11,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-11,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,432.725511,432.725511,1
HVTN,123,NAB,CH505.w4.3,123-11,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,125.60439,125.60439,1
HVTN,123,NAB,CH505TF,123-11,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-11,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-03,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,19.5541482,19.5541482,1
HVTN,123,NAB,CH505.w4.3,123-03,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,<10.0,5,0
HVTN,123,NAB,CH505TF,123-03,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-03,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-03,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,118.005341,118.005341,1
HVTN,123,NAB,CH505.w4.3,123-03,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,27.9148135,27.9148135,1
HVTN,123,NAB,CH505TF,123-03,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-03,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-33,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,67.9116162,67.9116162,1
HVTN,123,NAB,CH505.w4.3,123-33,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,21.3412373,21.3412373,1
HVTN,123,NAB,CH505TF,123-33,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-33,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-33,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,736.392606,736.392606,1
HVTN,123,NAB,CH505.w4.3,123-33,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,173.187925,173.187925,1
HVTN,123,NAB,CH505TF,123-33,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-33,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-37,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,10.6763567,10.6763567,1
HVTN,123,NAB,CH505.w4.3,123-37,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,<10.0,5,0
HVTN,123,NAB,CH505TF,123-37,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-37,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-37,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,10.2123661,10.2123661,1
HVTN,123,NAB,CH505.w4.3,123-37,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,<10.0,5,0
HVTN,123,NAB,CH505TF,123-37,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-37,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-42,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,122.866748,122.866748,1
HVTN,123,NAB,CH505.w4.3,123-42,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,41.8804162,41.8804162,1
HVTN,123,NAB,CH505TF,123-42,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-42,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-42,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,1263.57732,1263.57732,1
HVTN,123,NAB,CH505.w4.3,123-42,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,356.715143,356.715143,1
HVTN,123,NAB,CH505TF,123-42,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-42,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-38,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,33.1865758,33.1865758,1
HVTN,123,NAB,CH505.w4.3,123-38,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,13.9905779,13.9905779,1
HVTN,123,NAB,CH505TF,123-38,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-38,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-38,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,14.1374262,14.1374262,1
HVTN,123,NAB,CH505.w4.3,123-38,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,<10.0,5,0
HVTN,123,NAB,CH505TF,123-38,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-38,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-04,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,134.182485,134.182485,1
HVTN,123,NAB,CH505.w4.3,123-04,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,36.9815718,36.9815718,1
HVTN,123,NAB,CH505TF,123-04,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-04,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-04,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,348.597368,348.597368,1
HVTN,123,NAB,CH505.w4.3,123-04,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,98.1765574,98.1765574,1
HVTN,123,NAB,CH505TF,123-04,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,11.758047,11.758047,1
HVTN,123,NAB,CH505TF,123-04,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-13,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,214.537297,214.537297,1
HVTN,123,NAB,CH505.w4.3,123-13,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,50.6502095,50.6502095,1
HVTN,123,NAB,CH505TF,123-13,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-13,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-13,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,153.561867,153.561867,1
HVTN,123,NAB,CH505.w4.3,123-13,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,46.2396452,46.2396452,1
HVTN,123,NAB,CH505TF,123-13,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-13,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-10,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,85.3968853,85.3968853,1
HVTN,123,NAB,CH505.w4.3,123-10,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,19.8099405,19.8099405,1
HVTN,123,NAB,CH505TF,123-10,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-10,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-14,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,89.4383211,89.4383211,1
HVTN,123,NAB,CH505.w4.3,123-14,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,23.1358517,23.1358517,1
HVTN,123,NAB,CH505TF,123-14,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-14,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-29,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,497.773124,497.773124,1
HVTN,123,NAB,CH505.w4.3,123-29,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,141.399151,141.399151,1
HVTN,123,NAB,CH505TF,123-29,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-29,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-29,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,2226.58626,2226.58626,1
HVTN,123,NAB,CH505.w4.3,123-29,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,607.369435,607.369435,1
HVTN,123,NAB,CH505TF,123-29,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-29,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-48,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,295.469041,295.469041,1
HVTN,123,NAB,CH505.w4.3,123-48,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,57.260618,57.260618,1
HVTN,123,NAB,CH505TF,123-48,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-48,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-48,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,2009.83597,2009.83597,1
HVTN,123,NAB,CH505.w4.3,123-48,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,459.423133,459.423133,1
HVTN,123,NAB,CH505TF,123-48,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,11.4585106,11.4585106,1
HVTN,123,NAB,CH505TF,123-48,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-23,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,179.741082,179.741082,1
HVTN,123,NAB,CH505.w4.3,123-23,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,31.3763314,31.3763314,1
HVTN,123,NAB,CH505TF,123-23,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-23,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-23,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,1059.11488,1059.11488,1
HVTN,123,NAB,CH505.w4.3,123-23,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,289.842644,289.842644,1
HVTN,123,NAB,CH505TF,123-23,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-23,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-58,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,238.809618,238.809618,1
HVTN,123,NAB,CH505.w4.3,123-58,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,58.4208358,58.4208358,1
HVTN,123,NAB,CH505TF,123-58,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-58,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-58,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,1327.89833,1327.89833,1
HVTN,123,NAB,CH505.w4.3,123-58,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,311.729532,311.729532,1
HVTN,123,NAB,CH505TF,123-58,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-58,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-12,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,68.8387029,68.8387029,1
HVTN,123,NAB,CH505.w4.3,123-12,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,21.5258857,21.5258857,1
HVTN,123,NAB,CH505TF,123-12,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-12,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-12,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,1406.09324,1406.09324,1
HVTN,123,NAB,CH505.w4.3,123-12,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,500.67665,500.67665,1
HVTN,123,NAB,CH505TF,123-12,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-12,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-02,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,426.412092,426.412092,1
HVTN,123,NAB,CH505.w4.3,123-02,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,120.631947,120.631947,1
HVTN,123,NAB,CH505TF,123-02,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-02,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-02,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,1453.21758,1453.21758,1
HVTN,123,NAB,CH505.w4.3,123-02,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,405.226862,405.226862,1
HVTN,123,NAB,CH505TF,123-02,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-02,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-15,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,402.726075,402.726075,1
HVTN,123,NAB,CH505.w4.3,123-15,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,145.24673,145.24673,1
HVTN,123,NAB,CH505TF,123-15,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-15,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-15,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,1130.82532,1130.82532,1
HVTN,123,NAB,CH505.w4.3,123-15,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,328.776497,328.776497,1
HVTN,123,NAB,CH505TF,123-15,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-15,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-06,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,105.485527,105.485527,1
HVTN,123,NAB,CH505.w4.3,123-06,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,29.3803044,29.3803044,1
HVTN,123,NAB,CH505TF,123-06,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-06,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-06,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,1910.07769,1910.07769,1
HVTN,123,NAB,CH505.w4.3,123-06,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,516.449222,516.449222,1
HVTN,123,NAB,CH505TF,123-06,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-06,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-07,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,33.5363464,33.5363464,1
HVTN,123,NAB,CH505.w4.3,123-07,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,10.6019312,10.6019312,1
HVTN,123,NAB,CH505TF,123-07,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-07,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-07,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,198.900016,198.900016,1
HVTN,123,NAB,CH505.w4.3,123-07,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,77.0287232,77.0287232,1
HVTN,123,NAB,CH505TF,123-07,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-07,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-34,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,70.920817,70.920817,1
HVTN,123,NAB,CH505.w4.3,123-34,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,34.6307725,34.6307725,1
HVTN,123,NAB,CH505TF,123-34,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-34,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-34,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,143.493758,143.493758,1
HVTN,123,NAB,CH505.w4.3,123-34,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,35.5485389,35.5485389,1
HVTN,123,NAB,CH505TF,123-34,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-34,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-26,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,77.6843808,77.6843808,1
HVTN,123,NAB,CH505.w4.3,123-26,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,23.0382092,23.0382092,1
HVTN,123,NAB,CH505TF,123-26,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-26,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-26,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,307.880255,307.880255,1
HVTN,123,NAB,CH505.w4.3,123-26,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,108.625831,108.625831,1
HVTN,123,NAB,CH505TF,123-26,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-26,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-56,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,622.327347,622.327347,1
HVTN,123,NAB,CH505.w4.3,123-56,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,186.961043,186.961043,1
HVTN,123,NAB,CH505TF,123-56,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-56,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-56,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,677.192755,677.192755,1
HVTN,123,NAB,CH505.w4.3,123-56,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,199.811376,199.811376,1
HVTN,123,NAB,CH505TF,123-56,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-56,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-47,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,59.6555178,59.6555178,1
HVTN,123,NAB,CH505.w4.3,123-47,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,22.0519541,22.0519541,1
HVTN,123,NAB,CH505TF,123-47,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-47,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-47,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,375.451872,375.451872,1
HVTN,123,NAB,CH505.w4.3,123-47,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,135.741259,135.741259,1
HVTN,123,NAB,CH505TF,123-47,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-47,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-17,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,185.073719,185.073719,1
HVTN,123,NAB,CH505.w4.3,123-17,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,55.3609417,55.3609417,1
HVTN,123,NAB,CH505TF,123-17,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-17,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-17,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,282.714552,282.714552,1
HVTN,123,NAB,CH505.w4.3,123-17,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 1,66.3623058,66.3623058,1
HVTN,123,NAB,CH505TF,123-17,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-17,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",7,6.5,2 weeks post 3rd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505.w4.3,123-52,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,135.656755,135.656755,1
HVTN,123,NAB,CH505.w4.3,123-52,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 1,34.4609702,34.4609702,1
HVTN,123,NAB,CH505TF,123-52,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0
HVTN,123,NAB,CH505TF,123-52,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",5,2.5,2 weeks post 2nd vaccination,TZM-bl,tier 2,<10.0,5,0